The global Crohn’s disease market is estimated to grow at a significant CAGR of 4.2% during the forecast period. Crohn’s disease inflammation spreads into the layers of affected bowel tissues. Crohn’s disease is painful and may lead to life-threatening complications. Anti-inflammatory drugs, immune system suppressors, antibiotics, anti-diarrheal medications, pain relievers, iron supplements are also used during the treatment and recovery of Crohn’s disease. Crohn’s & Colitis Foundation launched a new open access journal in order to provide information to more than 3 million Americans living with IBD. Such platforms increase awareness among the population that further contribute to the growth of the market.
To Request a Sample of our Report on Crohn’s Disease Therapeutics Market: https://www.omrglobal.com/request-sample/crohns-disease-therapeutics-market
The market for Crohn’s disease is growing due to the increasing prevalence of Chron’s disease across the globe. The increasing prevalence of IBD results in the need for research for the prevention of (Inflammatory Bowel Disease) IBD and innovations in healthcare systems to manage this complex and costly disease. Crohn’s disease is an IBD type that causes chronic inflammation and damage in the gastrointestinal (GI) tract. Further, funding also leads to improving the quality of healthcare facilities. In 2018, Crohn’s & Colitis Foundation has received a $3.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to support IBD Qorus, the Foundation’s flagship quality of care program. Further, in 2018, Patient-Centered Outcomes Research Institute (PCORI) funded $2.4 million to Crohn’s & Colitis Foundation in order to study the comparative effectiveness of biologic or small molecule therapies in IBD. Such funding programs in order to increase awareness and R&D are contributing to market growth.
(Get 15% Discount on Buying this Report)
A full Report of Crohn’s Disease Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/crohns-disease-therapeutics-market
Global Crohn’s disease Therapeutics Market Segmentation
By Treatment Type
- Surgery
- Anti- Inflammatory Drug Administration
- Steroids
- Immunosuppressant
- Biological Drugs
- Amino salicylates
- Others
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of The World
Company Profiles
- Abbott Laboratories
- AbbVie Inc.
- Allergan, PLC
- Boehringer Ingelheim International GmbH
- Celgene Corp.
- Daiichi Sankyo Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann-La Roche AG
- GlaxoSmithKline PLC
- Johnson & Johnson Services Inc.
- Laboratory Corporation of America Holdings
- Mercator Pharmaceutical Solutions
- Pfizer Inc.
- Pharmacosmos A/S
- RPG Life Sciences Ltd.
- Sanofi S.A.
- Takeda pharmaceutical Co., Ltd.
- UCB, Inc.
- Vifor Pharma Group
Reasons to Buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/crohns-disease-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
